Related Experiment Video

Updated: Aug 9, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex

Audrey Robinson-White1, Elise Meoli, Sotirios Stergiopoulos

  • 1Section on Endocrinology and Genetics, and Pediatric Endocrinology Training Program, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

The Journal of Clinical Endocrinology and Metabolism
|March 30, 2006
PubMed
Abstract

Insights

Mutations in PRKAR1A (mt-PRKAR1A) increase protein kinase A (PKA) activity and MAPK signaling in adrenocortical tissue. This dysregulation may drive primary pigmented nodular adrenocortical disease development.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Primary pigmented nodular adrenocortical disease (PPNAD) is linked to Carney complex and PRKAR1A gene mutations.
  • PRKAR1A mutations disrupt cAMP-dependent protein kinase (PKA) regulation, potentially leading to tumorigenesis.
  • Lymphocytes with mt-PRKAR1A exhibit increased proliferation and MAPK ERK1/2 pathway activation.

Purpose of the Study:

  • To investigate alterations in PKA subunits and ERK1/2 signaling pathways in adrenocortical tissue from patients with PRKAR1A mutations.
  • To understand the molecular mechanisms underlying PKA and MAPK pathway dysregulation in the context of mt-PRKAR1A.

Main Methods:

  • Analysis of PKA activity, subunit expression (mRNA and protein), and ERK1/2 signaling in adrenocortical samples.
  • Utilized quantitative mRNA assays, immunoblotting, immunoassays, and immunohistochemistry.
  • Compared samples from patients with germline normal PRKAR1A versus those with mt-PRKAR1A.

Main Results:

  • Adrenocortical tissue with mt-PRKAR1A showed increased cAMP-stimulated PKA activity.
  • Significant decreases in RIalpha mRNA and protein were observed, with increases in other PKA subunits.
  • MAPK pathway components, including ERK1/2, p-MEK1/2, and p-c-Myc, were significantly altered, indicating enhanced activity.

Conclusions:

  • mt-PRKAR1A leads to increased PKA activity, potentially due to RIalpha downregulation and other PKA subunit upregulation.
  • Enhanced MAPK signaling, alongside altered PKA activity, may contribute to the proliferative signals driving PPNAD.
  • Findings in human adrenocortical tissue align with observations in lymphocytes and animal models.

More Related Videos

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...